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Appendage regeneration is defined by rapid changes in
gene expression that achieve dramatic developmental ef-
fects, suggesting involvement of microRNAs (miRNAs).
Here, we find dynamic regulation of many miRNAs dur-
ing zebrafish fin regeneration. In particular, miR-133 lev-
els are high in uninjured fins but low during regenera-
tion. When regeneration was blocked by Fibroblast
growth factor (Fgf) receptor inhibition, high miR-133 lev-
els were quickly restored. Experimentally increasing
amounts of miR-133 attenuated fin regeneration. Con-
versely, miR-133 antagonism during Fgf receptor inhibi-
tion accelerated regeneration through increased prolif-
eration within the regeneration blastema. The Mps1 ki-
nase, an established positive regulator of blastemal
proliferation, is an in vivo target of miR-133. Our find-
ings identify miRNA depletion as a new regulatory
mechanism for complex tissue regeneration.
Supplemental material is available at http://www.genesdev.org.
Received December 10, 2007; revised version accepted
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Regeneration, the replacement of damaged or lost body
parts, is a primary goal of stem cell research. Certain
nonmammalian vertebrates like urodele amphibians and
teleost fish restore complex tissues much more effec-
tively than mammals, creating tantalizing examples of
successful organ regeneration. For instance, the common
laboratory model zebrafish regenerates heart muscle,
retina, spinal cord, sensory hair cells, and appendages
(Stoick-Cooper et al. 2007). Fin regeneration in zebrafish
is a particularly efficient example of complex tissue re-
generation, replacing bone, epidermis, blood vessels,
nerves, connective tissue, and pigmentation within 2 wk
of amputation of up to 95% of the organ. Following
wound healing, spared mesenchymal cells disorganize,
migrate distally, and accumulate to form the regenera-
tion blastema, a proliferative mass of progenitor tissue.
The blastema is maintained throughout the process of
regenerative outgrowth, during which it creates new
structures through a series of proliferation, patterning,
and differentiation events. During fin regeneration and
other examples of complex tissue regeneration, large-
scale changes in gene expression programs occur to ex-
ecute the rapid transformation of quiescent, differenti-
ated tissue to proliferating, actively patterned tissue
(Lien et al. 2006; Schebesta et al. 2006).
To implement these programmatic alterations in gene
expression, it is almost certain that several modes of
regulation are employed. These might include changes
in chromatin accessibility and new production of tran-
scriptional factors, as well as post-transcriptional
mechanisms. Based on studies in other fields, micro-
RNAs (miRNAs) present excellent candidates to mediate
important post-transcriptional regulation during com-
plex tissue regeneration. miRNAs are small, noncoding
RNAs that base-pair with complementary sequences in
the 3 untranslated regions (UTRs) of target genes to pro-
mote mRNA degradation or inhibit protein translation
(Kloosterman and Plasterk 2006). The first identified
miRNAs, lin-4 and let-7, were discovered in genetic
screens for mutations that disrupt developmental tran-
sitions in nematodes (Lee et al. 1993; Reinhart et al.
2000). miR-430 is the predominant miRNA species in
early zebrafish embryos, where it refines the transition
from maternal to zygotic mRNA utilization and helps
balance levels of patterning factors (Giraldez et al. 2006;
Choi et al. 2007). Investigators have also identified con-
tributions by miRNAs to preventing or promoting the
pathology of adult organs. In particular, miR-133 and
miR-208 modulate pathologic cardiac muscle hypertro-
phy in mouse models of this common human cardiomy-
opathy, where they appear to have opposing functions
(Care et al. 2007; van Rooij et al. 2007). Given the nu-
merous roles for various miRNAs in different develop-
mental processes like organogenesis, stem cell mainte-
nance, and programmed cell death, as well as in adult
pathogenesis, there is reason to suspect involvement in
spectacular regenerative events of teleosts and urodele
amphibians.
Here, we found that many miRNAs are differentially
regulated during caudal fin regeneration in adult ze-
brafish. One of these miRNAs, miR-133, has relatively
high levels in the uninjured fin, but these levels drop
sharply during regeneration. By a combination of gain-
of-function and loss-of-function experiments, our data
indicate that miR-133 acts as a regenerative brake within
a regulatory circuit for regeneration. Following amputa-
tion, Fibroblast growth factor (Fgf) signaling reduces
miR-133 expression as part of the regeneration program,
facilitating normal expression of targets like the mps1
kinase that direct blastemal proliferation and tissue re-
newal. Our findings identify miR-133 depletion as an
important regulatory mechanism by which Fgfs promote
appendage regeneration.
Results and Discussion
Caudal fin regeneration is accompanied by alterations
in miRNA expression
To identify miRNAs present during caudal fin regenera-
tion, we performed miRNA microarray experiments us-
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ing RNA collected from three phases of regeneration: (1)
newly amputated fins (0 d post-amputation, dpa), (2) for-
mation of the blastema (1 dpa, at 33°C), and (3) early
regenerative outgrowth (3 dpa) (Fig. 1A). These analyses
indicated dynamic miRNA regulation during regenera-
tion. During blastema formation, 24 miRNAs showed
significantly higher expression levels compared with un-
injured fins, while 13 miRNAs exhibited lower expres-
sion levels (0 dpa compared with 1 dpa; 1.5-fold change).
During regenerative outgrowth, 51 miRNAs showed sig-
nificantly higher expression levels, and 14 miRNAs had
lower levels than uninjured fins (3 dpa compared with 0
dpa; 1.5-fold change) (Supplemental Fig. 1A). Levels of
some miRNAs differed between blastema formation and
regenerative outgrowth, suggesting stage-specific func-
tions, and many of these expression profiles were vali-
dated by Northern analysis (Fig. 1A). Thus, numerous
miRNAs are differentially regulated during zebrafish fin
regeneration.
Fgfs control miRNA expression during fin regeneration
Multiple lines of experimental evidence have demon-
strated that signaling by Fgfs is indispensable for fin re-
generation (Poss et al. 2000; Lee et al. 2005; Whitehead et
al. 2005; Thummel et al. 2006). These studies led to a
regulatory model in which Fgf ligands like Fgf20a and
Fgf24 induce blastema formation after amputation and
then continue to maintain blastemal cell proliferation
during regenerative outgrowth. To determine whether
Fgf signaling controls expression of specific miRNAs
during regenerative outgrowth, we used a transgenic ze-
brafish strain that carries a heat-inducible dominant-
negative Fgf receptor (Fgfr; hsp70:dn-fgfr1). This con-
struct is predicted to block signaling through all Fgfrs
and effectively disrupts regeneration of fin and cardiac
tissue in animals given daily heat shocks (Lee et al. 2005;
Lepilina et al. 2006). In these experiments, wild-type and
transgenic animals were allowed to regenerate normally
for 4 d (at 26°C), followed by a single heat shock to in-
duce dn-fgfr1 expression. Just 5 h after the heat shock
was completed, RNA was collected from regenerates and
hybridized onto miRNA microarrays. These experi-
ments revealed 22 miRNAs that were expressed at lower
levels during Fgfr inhibition than in wild-type regener-
ates (wild type, 4 dpa vs. hsp70:dn-fgfr1, 4 dpa; 1.5-fold),
with 34 other miRNAs exhibiting higher expression lev-
els (Fig. 1B; Supplemental Fig. 1B). To assist identifica-
tion of Fgf-regulated miRNAs, we fil-
tered these data with an additional
data set of uninjured wild-type fins (0
dpa). Of those 22 miRNAs that were
expressed at lower levels in hsp70:dn-
fgfr1 4-dpa samples, six of these were
also among the 27 miRNAs increased
from 0 to 4 dpa in wild-type fins. Of
the 34 miRNAs with higher levels
during Fgfr inhibition, 16 were among
the 54 miRNAs with levels that fall
from 0 to 4 dpa in wild-type fins
(Supplemental Fig. 1B). Northern
analysis has confirmed several ex-
pression profiles from our filtered
data set (data not shown). Thus, our
microarray experiments point to a to-
tal of 22 miRNAs influenced by Fgf
signaling during regeneration, six of
which are induced or maintained by
Fgf signaling, and 16 negatively regu-
lated (Supplemental Fig. 1C).
miR-133 is depleted by Fgf signaling
during fin regeneration
Because of its expression profile dur-
ing regeneration, we focused our at-
tention on miR-133, a highly con-
served family of miRNAs that has
been recently implicated in regulat-
ing cardiac and skeletal muscle devel-
opment, as well as differentiation and
function of dopaminergic neurons
(Chen et al. 2006; Care et al. 2007;
Kim et al. 2007). The miR-133 family
has four members encoded by differ-
ent genes that vary only by 2 nucleo-
tides (nt) in the mature species, out-
side of the predicted seed sequence.
miR-133b was the only member dis-
playing strong expression of the pre-
Figure 1. miRNAs are dynamically regulated during zebrafish caudal fin regeneration. (A,
left) Tissue distal to a region one ray segment proximal to the amputation plane (red arrow)
was collected from wild-type (wt) fins at 0, 1, or 3 dpa and used for RNA isolation and miRNA
microarray analysis. (Right) Northern analyses of various miRNAs present during fin regen-
eration. (B) A heat map comparing relative miRNA expression in wild-type and hsp70:dn-fgfr1
4-dpa regenerates collected 5 h after a single heat shock at 38°C. (Green) Lower expression;
(red) higher expression; (asterisk) miR-133. (C) Ribonuclease protection assays (RPAs) were
performed using RNA collected from wild-type regenerates at the indicated stages. (D, top)
RPA using RNA collected from wild-type or hsp70:dn-fgfr1 samples. miR-133 levels are re-
duced during regenerative outgrowth (compare wild type, 0 dpa vs. wild type, 4 dpa), but are
restored during a brief period of Fgfr inhibition at 4 dpa. (Bottom) Northern analysis with a 5s
rRNA probe was used as a control.
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cursor species in caudal fins by Northern analysis, sug-
gesting that it is the predominant member in this tissue
(data not shown). miR-133 was detectable at relatively
high levels in the uninjured adult caudal fin, but its ex-
pression was 5.6-fold lower during regenerative out-
growth. A time course of miR-133 expression during
wild-type fin regeneration showed that levels were re-
duced during blastema formation and remained low un-
til 14 dpa (at 26°C) (Fig. 1C). By 30 dpa, a point at which
fin regeneration has been completed, levels of miR-133
were not restored but appeared to be approaching those
levels within uninjured fins.
Interestingly, when Fgfrs were briefly inhibited during
regenerative outgrowth, a 4.5-fold increase in the level of
miR-133 was observed (Fig. 1B,D; Supplemental Fig. 1A),
restoring approximately the miR-133 level of uninjured
fins. To determine if this response was specific to regen-
eration, we assessed the effects of Fgfr inhibition on
miR-133 levels in uninjured adult fins. Blockade of Fgf
signaling in uninjured fins did not elevate levels of miR-
133, indicating regeneration-specific regulation (data not
shown). Collectively, these expression data suggested a
model in which Fgf signaling depletes miR-133 during
fin regeneration.
miR-133 functions as a regenerative brake
miR-133 levels were higher in uninjured fins than during
the regenerative process, suggesting that miR-133 at-
tenuates growth mechanisms. To determine the effects
of experimentally increasing levels of miR-133 during
regeneration, we injected and electroporated miR-133
RNA duplexes into wild-type fin regenerates (Fig. 2A,B).
We found that dorsal lobe regenerates electroporated
with miR-133 duplexes had an ∼10% reduction in length
compared with uninjected ventral lobe regenerates when
measured 24 h after introduction, and an ∼13% reduc-
tion when measured 3 d after electroporation (Fig. 2B,D;
Supplemental Fig. 3A). These measurements conserva-
tively estimate the effects on regeneration, since the first
3 d of regeneration proceed normally prior to electropora-
tion. Also, it is possible that the percentage of cells af-
fected or relative miR-133 increases in these studies are
low. Electroporation with a mutated miR-133 RNA
duplex, containing 3-nt changes in the predicted seed
region, had no significant effects on regeneration
(Fig. 2C,D; Supplemental Fig. 2D). Intrafin comparisons
of injected and uninjected fin lobes were also made to
eliminate possible interfish variability in the lengths of
regenerates. Regenerates injected with miR-133 RNA
duplex showed significantly lower injected:uninjected
length ratios (11%–14% at 1, 2, and 3 d post-injection)
than regenerates injected with mutated RNA du-
plex (Fig. 2D). These results indicate that miR-133
slows regenerative outgrowth and support the idea that
fin regeneration is assisted by regulated depletion of
miR-133.
miR-133 antagonism accelerates regeneration during
Fgfr inhibition
To test the effects of antagonizing miR-133 function dur-
ing regeneration, an antisense morpholino (MO) de-
signed to disrupt miR-133 binding and activity was in-
troduced into regenerating wild-type caudal fins. No sig-
nificant effects on regenerate length were observed
during the first 2 d following miR-133 MO electropora-
tion; however, an ∼10% increase in length was evident
by the third day (Supplemental Fig. 4). This minor effect
may have been due to the fact that miR-133 levels are
already quite low during regeneration. We hypothesized
that we might achieve a greater effect during Fgfr inhi-
bition, given that miR-133 levels increase under these
conditions. Indeed, antagonizing miR-133 function in
hsp70:dn-fgfr1 regenerates partially restored fin regen-
eration. miR-133 MO-treated dorsal lobe regenerates
were ∼17% longer than uninjected ventral lobe regener-
ates by 1 d after electroporation (Fig. 2C). By 3 d after
electroporation, miR-133 MO-treated regenerates were
an average of ∼44% longer than uninjected regenerates
(Supplemental Fig. 3). In contrast, electroporation of a
standard MO that is not predicted to interact with an
expressed RNA had no significant effects on regenera-
tion. Intrafin data showed significantly higher inject-
ed:uninjected length ratios in miR-133 MO-treated fins
versus standard MO-treated fins of ∼20%, ∼41%, and
∼50% at 1, 2, and 3 d post-injection (Fig. 2E). Thus, miR-
133 is a significant regulatory target of Fgf signaling dur-
Figure 2. Experimental manipulation of miR-133 controls fin re-
generation. (A) Design for RNA duplex (blue) and MO (red) electro-
poration studies. (B) Electroporation of miR-133 RNA duplex into
the dorsal lobe (top, blue asterisk) slows regeneration in wild-type
fins, as compared with a mutated miR-133 RNA duplex (bottom,
black asterisk). (C) Electroporation of miR-133 MO into the dorsal
lobe (top, red asterisk) enhances regeneration during Fgfr inhibition,
as compared with a standard MO (bottom, black asterisk). (D,E)
Quantification of average intrafin length ratios of injected versus
uninjected fin lobes with miR-133 RNA duplex (D) or miR-133 MO
(E). The injected:uninjected length ratio is significantly reduced by
miR-133 duplex introduction, but significantly increased by miR-
133 MO introduction (mean ± SEM; [*] P < 0.05, t-test; n = 10 per
group).
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ing fin regeneration. Antagonism of miR-133 activity is
sufficient to partially rescue fin regeneration that has
been inhibited by Fgfr blockade.
To determine the mechanism by which miR-133 im-
pacts regeneration, we first quantified blastemal cell pro-
liferation using BrdU incorporation assays. While a stan-
dard MO had no effect on the number of BrdU-labeled
cells in hsp70:dn-fgfr1 regeneration blastemas, miR-133
MO-treated blastemas had ∼28% more BrdU-positive
cells than uninjected blastemas (Fig. 3A,B). Intrafin com-
parisons showed an ∼29% increase in the injected:unin-
jected ratio of BrdU-positive cells in miR-133 MO-
treated regenerates versus those treated with standard
MO (Fig. 3A,B). To determine whether the rescue we
observed included partial restoration of regeneration pro-
grams, we examined expression of markers that are nor-
mally activated during fin regeneration by quantitative
PCR. We found that the Fgf target gene mkp3, the basal
epidermal marker lef1, and the blastemal markers msxb
and mps1 each displayed elevated expression in
hsp70:dn-fgfr1 regenerates injected with the miR-133
MO, while -actin1 levels showed no significant change
(Fig. 3C). Because lef1, mkp3, and msxb lack a predicted
binding site for miR-133, the effects of the miR-133 MO
are most likely indirect. These results indicate that miR-
133 antagonism partially rescues regeneration by in-
creasing the expression of regeneration genes and en-
abling cellular proliferation.
mps1 is an in vivo target of miR-133
miRNAs typically have from several dozen to hundreds
of different mRNA target genes (Lewis et al. 2005; Giral-
dez et al. 2006). We searched the miRanda and miRBase
databases and identified many potential targets, as pre-
dicted by complementarity of miR-133 seed sequences
with mRNA 3 UTR sequences. These potential targets
include factors that support cellular and molecular func-
tions previously implicated in regeneration, including
cell division and growth, metalloproteinase activity
(Vinarsky et al. 2005), and ion flux (Supplemental Table
1; Adams et al. 2007). One gene containing a single pre-
dicted miR-133-binding site is mps1, which encodes a
kinase that regulates multiple aspects of cell prolifera-
tion during morphogenesis, including centrosome dupli-
cation, spindle checkpoint activation, and normal mi-
totic progression (Fisk and Winey 2004). Most impor-
tantly, mps1 is one of only four genes to date that have
been shown by forward genetic approaches to be essen-
tial for fin regeneration. mps1 expression is specifically
induced in blastemal tissue during regeneration, and a
temperature-sensitive mutation in mps1 arrests regen-
eration during outgrowth, the phase at which our data
implicated miR-133 function (Poss et al. 2002).
To determine if miR-133 regulates mps1 mRNA in
vivo, we used zebrafish embryo sensor assays (Giraldez
et al. 2005). We injected a sensor mRNA construct con-
sisting of EGFP fused to the 3 UTR of mps1 into one-cell
zebrafish embryos, in the presence or absence of miR-
133 RNA duplex (Fig. 4A). One day later, we quantified
EGFP fluorescence as an indicator of Mps1 expression.
Injections of the mps1 sensor mRNA alone resulted in
high EGFP expression; however, this fluorescence was
dampened almost 50% by coinjection of miR-133 RNA
duplex (Fig. 4A). Three additional experiments provided
evidence of specific interaction between miR-133 and
the EGFP-mps1-3 UTR sensor mRNA. First, no interac-
tion was observed between miR-133 and a sensor mRNA
containing a mutated miR-133-binding site. Second,
coinjected miR-101 RNA duplex, not predicted to regu-
late the mps1 3 UTR, did not reduce EGFP sensor fluo-
rescence. Finally, coinjection of miR-133 MO or an
LNA-133 antisense oligonucleotide effectively pre-
vented miR-133-induced dampening of fluorescence (Fig.
4A,B). Northern blot analysis indicated little or no effect
of miR-133 duplex on EGFP-mps1-3 UTR sensor mRNA
levels (data not shown). Therefore, we suspect that miR-
133 regulates mps1 in these assays through translational
repression. This finding suggests that the increases in
mps1 mRNA levels we observed after antagonism of
miR-133 during fin regeneration were likely contributed
by other direct and indirect regulatory inputs (Fig. 3C). In
summary, the known blastemal regulator mps1 is a tar-
get of miR-133.
Conclusions
In conclusion, our experiments implicate post-transcrip-
tional regulation by miRNAs in the process of complex
Figure 3. miR-133 regulates blastemal cell proliferation. (A,B)
hsp70:dn-fgfr1 animals were treated as in Figure 2A with miR-133
MO and injected with BrdU. (A, boxes) Dorsal regenerates treated
with miR-133 MO show ∼28% greater blastemal BrdU incorporation
than uninjected ventral regenerates. The standard MO had no sig-
nificant effects on blastemal BrdU incorporation. (C) Quantitative
PCR results indicating increased expression of the regeneration
markers lef1, mkp3, msxb, and mps1 in hsp70:dn-fgfr1 regenerates
treated with miR-133 MO. Expression levels of -actin1 were unaf-
fected by miR-133 MO treatment. Data are expressed as ratios of
injected:uninjected lobes. (Solid bars) miR-133 MO; (hatched bars)
standard MO. (Mean ± SEM; [*] P < 0.05; n = 14–16 fins per group for
BrdU studies.)
miR-133 controls fin regeneration
GENES & DEVELOPMENT 731
tissue regeneration. We identified many miRNAs in ze-
brafish appendages that showed sharp increases or de-
creases in expression during the transition from unin-
jured to regenerating tissue. Normal expression of sev-
eral miRNAs during regeneration is dependent on intact
Fgf signaling. Through both gain-of-function and loss-of-
function experiments, our data reveal that miR-133 is a
regenerative brake whose regulated depletion ensures
optimal fin regeneration.
Our findings support a model in which miR-133 levels
are diminished by Fgf signaling, a critical pathway for
regeneration that is activated within hours of fin ampu-
tation, maintained throughout the process, and progres-
sively subdued as final structures are replaced (Fig. 4C;
Lee et al. 2005; Whitehead et al. 2005). How miR-133
depletion is triggered by Fgfs mechanistically remains to
be determined and may be relevant to other Fgf-depen-
dent developmental events. Lowering miR-133 levels
augments blastemal proliferation through regulation of
genes like mps1, optimizing regeneration. Thus, miRNA
function is integrated into a regulatory circuit that com-
mences via the Fgf signaling pathway and is consum-
mated through a known regulator of blastemal prolifera-
tion (Fig. 4C). Given the cellular functions of other pre-
dicted miR-133 targets, as well as data from previous
miRNA studies, we suspect that there are targets of miR-
133 in addition to mps1 that are important for its effects
on regeneration (Kloosterman and Plasterk 2006).
miR-133 depletion represents an intriguing form of
regulation during complex tissue regeneration. We
speculate that animals with enhanced regenerative ca-
pacity like zebrafish and axolotls carry an arsenal of tun-
ing mechanisms that maintain the differentiated state
and/or preclude unwelcome activation of growth mecha-
nisms. In turn, these tuning mechanisms are repressed
upon injury to facilitate regeneration. Thus, it is possible
that regulated restriction of steady-state levels of specific
miRNAs like miR-133 by early or persistent regenera-
tion signals like Fgfs is a recurring theme in regenerative
morphogenesis. Our observation that levels of multiple
different miRNAs are lowered during fin regeneration
supports this idea. Conversely, miRNAs we identified
with increased levels during regenerative outgrowth
might help restrict cellular differentiation programs and/
or balance the formation and proliferation of blastemal
cells. Indeed, we predict that there is an abundance of
fascinating mechanistic information about regenerative
events to be gained from functional exploration of the
many miRNAs that are differentially expressed during
fin regeneration. With respect to regenerative medicine,
our findings suggest that tactical modulation of key
miRNAs and their target populations may be sufficient
to revise the regenerative capacity of vertebrate organs.
Materials and methods
Zebrafish caudal fin amputations
Zebrafish of the Ekkwill (EK) strain or EK/AB mixed strain 4–6 mo old
were used for all experiments. Amputations were performed with a razor
blade and removed one-half of the caudal fin. In Figure 1A experiments,
samples were collected from wild-type animals and allowed to regenerate
at 33°C, a temperature that accelerates the process. For all other experi-
ments, regeneration occurred at 26°C. Heat shocks were given at 38°C to
wild-type and hsp70:dn-fgfr1 animals as described (Lee et al. 2005).
Gene expression analysis
Total RNA was isolated (Tri-Reagent; Sigma) from tissue distal to a re-
gion one segment proximal to the amputation plane and used for miRNA
microarray hybridizations, Northern analysis, quantitative PCR, and ri-
bonuclease protection assays (see Supplemental Material).
MO and RNA duplex injections
Wild-type and hsp70:dn-fgfr1 caudal fins were amputated and allowed to
regenerate for 3 d at 26°C. MOs (Gene-Tools) or RNA duplexes (IDT
Technology; design based on miR-133b sequence) (see Supplemental
Table 2; Supplemental Fig. 2) were injected into each ray of the dorsal
lobe, followed by electroporation of the entire caudal fin using a 5-mm
electrode (Thummel et al. 2006; Visvanathan et al. 2007). Fluorescein-
tagged MOs were used to monitor electroporation efficiency. When
hsp70:dn-fgfr1 regenerates were treated with MOs, electroporation oc-
curred 5 h after a single heat shock at 38°C. Regenerates were imaged
daily for 3 d following electroporation and measured from the amputa-
tion plane to the distal tip of regenerating rays 2 and 3 (with respect to the
most lateral ray) for dorsal and ventral lobes, using Openlab software.
The lengths of these rays were averaged to give one length value each for
the dorsal and ventral regenerates per animal. Intrafin ratios represent
injected dorsal regenerate length:uninjected ventral regenerate length,
calculated for each animal at each time point. Student’s t-tests (two-
tailed, unequal variance) were performed to determine P-values.
BrdU analysis
A 2.5 mg/mL BrdU solution was injected intraperitoneally into hsp70:dn-
fgfr1 animals 5 h after MO injection. After 30 min, caudal fins were
collected and processed for immunofluorescence as described (Lee et al.
2005). We quantified the number of BrdU-positive cells by counting
within a 0.036-mm2 box, based on the average size of 4-dpa, BrdU-dense
blastemas of wild-type animals that had been heat-shocked and electro-
porated with a standard control MO. Each square was aligned at the distal
edge of the regenerate in hsp70:dn-fgfr1 MO-treated fin rays. For each fin,
BrdU-positive cells in dorsal rays 2 and 3 were counted for MO effects,
while ventral rays 2 and 3 were counted for the uninjected control.
Figure 4. miR-133 targets the blastemal regulator mps1. (A,B)
EGFP embryo sensor assays demonstrating specific regulation of the
mps1 3 UTR in vivo by miR-133. For each experimental group in B,
EGFP-mps1-3 UTR fluorescence is expressed as a percentage of
fluorescence observed from the sensor injected alone. (A, bottom)
DsRed mRNA is injected as a control. (Mean ± SEM; [*] P < 0.05;
n = 10 embryos per group.) (C) Model for miR-133 function during
fin regeneration. Fin amputation triggers Fgf signaling, which at-
tenuates miR-133 levels through unknown mechanisms. The reduc-
tion in miR-133 levels boosts expression of target genes important
for blastemal proliferation like Mps1, optimizing regeneration.
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EGFP sensor assays
One-cell zebrafish embryos were injected with 1–2 nL of a solution con-
sisting of 150 ng/µL sensor mRNA and 100 ng/µL Dsred mRNA. When
applicable, 10 µM miRNA duplex was added with or without 0.5 ng/µL
miR-133 MO or 0.8 ng/µL LNA-133. EGFP fluorescence was quantified at
24–28 h post-fertilization as described (Giraldez et al. 2006).
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